ANIP.OQ - ANI Pharmaceuticals Inc
Guggenheim Securities LLCEstimate Revision, Price Target Revision
ANIP: Commentary Around 1Q 2026 Cortrophin Dynamics Pressures Stock, But FY 2026 Growth Outlook Remains Very Robust; Reiterate Buy, $124 PT; 4Q 2025 Earnings Recap
公司
ANIP.OQ
日期
2026-03-01
分析师
Mr. Vamil K. Divan, MD
页数
9 页
需要登录
请登录后购买研报或生成音频内容。